Picture of PURE Biosciences logo

PURE PURE Biosciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Annual balance sheet for PURE Biosciences, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

2019
July 31st
2020
July 31st
2021
July 31st
2022
July 31st
2023
July 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.3983.842.393.391.09
Net Total Accounts Receivable
Net Total Receivables0.3731.090.3680.2010.285
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets1.045.573.23.861.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.3620.3160.740.620.221
Net Intangible Assets
Total Assets1.936.324.34.481.82
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities0.7381.510.970.5750.532
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.7421.510.970.5751.55
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity1.194.813.333.910.272
Total Liabilities & Shareholders' Equity1.936.324.34.481.82
Total Common Shares Outstanding